Pancreatic Cancer Research

ResearcherOntario Institute for Cancer ResearchActive in the last 2 years

Sangeetha N. Kalimuthu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2115-3757; OpenAlex author ID A5019026422. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
55
Papers, trials and grants by year

2017: 2 papers · 2018: none · 2019: none · 2020: 3 papers · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 8

  1. Salvage Radiotherapy in Isolated Locoregional Recurrence of Pancreatic Adenocarcinoma Post-Radical Surgical Resection: Prudent or Pointless? A Retrospective Co… Co-author DOI 10.3390/curroncol33060337↗
  2. Whole genome and transcriptome profiling in advanced pancreatic cancer patients on the COMPASS trial. Co-author DOI 10.1038/s41467-025-60808-z↗
  3. A Risk Score Model for Locoregional Recurrence Following Upfront Surgery for Pancreatic Adenocarcinoma: Implications for Adjuvant Therapy. Co-author DOI 10.1016/j.clon.2021.03.007↗
  4. Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution. Co-author DOI 10.1038/s41588-019-0566-9↗
  5. Author Correction: Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution. Co-author DOI 10.1038/s41588-020-0588-3↗
  6. Morphological classification of pancreatic ductal adenocarcinoma that predicts molecular subtypes and correlates with clinical outcome. Co-author DOI 10.1136/gutjnl-2019-318217↗
  7. Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1001/jamaoncol.2016.3916↗
  8. Regression grading in neoadjuvant treated pancreatic cancer: an interobserver study. Co-author DOI 10.1136/jclinpath-2016-203947↗

Closest collaborators

The 25 strongest of 55 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Steve Gallinger · 6 shared papers, 2017–2025 · strength 0.55
  2. Grainne Mary O'Kane · 5 shared papers, 2020–2025 · strength 0.51
  3. Robert C. Grant · 5 shared papers, 2017–2025 · strength 0.45
  4. Faiyaz Notta · 5 shared papers, 2017–2025 · strength 0.45
  5. Erica S. Tsang · 2 shared papers, 2025–2026 · strength 0.44
  6. Jennifer Jane Knox · 4 shared papers, 2020–2025 · strength 0.39
  7. Ali Hosni · 2 shared papers, 2021–2026 · strength 0.39
  8. Michelle Chan‐Seng‐Yue · 4 shared papers, 2017–2025 · strength 0.34
  9. Runjan Chetty · 4 shared papers, 2017–2020 · strength 0.33
  10. Sandra Elisabeth Fischer · 3 shared papers, 2020–2025 · strength 0.30
  11. George Zogopoulos · 3 shared papers, 2020–2025 · strength 0.30
  12. Colin Faulkner · 1 shared paper, 2026 · strength 0.29
  13. Ayah Erjan · 1 shared paper, 2026 · strength 0.29
  14. Aruz Mesci · 1 shared paper, 2026 · strength 0.29
  15. Malcolm J. Moore · 2 shared papers, 2017–2025 · strength 0.20
  16. Ashton Anthony Connor · 3 shared papers, 2017–2020 · strength 0.18
  17. Spring Holter · 1 shared paper, 2025 · strength 0.15
  18. Ravi Ramjeesingh · 1 shared paper, 2025 · strength 0.15
  19. Sheron Perera · 1 shared paper, 2025 · strength 0.15
  20. Mustapha Ali Tehfe · 1 shared paper, 2025 · strength 0.15
  21. Joan Miguel Romero · 1 shared paper, 2025 · strength 0.15
  22. Barbara T. Grünwald · 1 shared paper, 2025 · strength 0.15
  23. Raymond Jang · 1 shared paper, 2025 · strength 0.15
  24. Yifan Wang · 1 shared paper, 2025 · strength 0.15
  25. Tae Kyoung Kim · 1 shared paper, 2025 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.